Table 1.
Characteristics of the population who were enrolled at baseline and who concluded the study
|
Total population |
Enrolled (n = 914) |
Concluding the study (n = 816) |
|||||
|---|---|---|---|---|---|---|---|
| Groups | NO ICS (n = 368) | ICS (n = 546) | p-value | NO ICS (n = 334) | ICS (n = 482) | p-value | |
|
Gender (%F) |
30% |
27% |
0.4102 |
30% |
27% |
0.2817 |
|
|
Age (Yrs) |
72.0 (9.5) |
72.8 (9.1) |
0.1750 |
72.1 (9.2) |
73.0 (8.9) |
0.1936 |
|
|
BMI |
27.6 (5.1) |
28.3 (5.1) |
0.0600 |
27.8 (5.1) |
28.4 (5.1) |
0.1458 |
|
|
Smoking history° (%Y) |
82% |
91% |
0.0007 |
83% |
91% |
0.0019 |
|
|
Ex-smokers |
60% |
69% |
0.0047 |
60% |
68% |
0.0187 |
|
|
Smokers |
22% |
22% |
1.0000 |
23% |
23% |
1.0000 |
|
|
Years since diagnosis |
6.8 (6.7) |
6.6 (6.0) |
0.5401 |
6.8 (6.6) |
6.6 (6.0) |
0.6794 |
|
|
VC (%pred) |
91.5 (15.9) |
95.2 (19.5) |
0.0054 |
91.4 (15.7) |
94.7 (18.6) |
0.0124 |
|
|
FEV
1
(%pred) |
71.7 (10.4) |
70.8 (11.3) |
0.2608 |
71.6 (10.5) |
71.1 (11.4) |
0.5293 |
|
|
FEV
1
/VC |
0.60 (0.08) |
0.59 (0.08) |
0.2679 |
0.60 (0.08) |
0.59 (0.08) |
0.1865 |
|
|
CAT |
15.9 (8.5) |
14.8 (7.8) |
0.0717 |
16.0 (8.6) |
14.8 (7.8) |
0.0528 |
|
|
Exacerbations (0/1) |
135/233 |
206/340 |
0.802 |
127/207 |
186/296 |
0.928 |
|
|
Comorbidities: 0 |
116 (32%) |
130 (24%) |
0.012 |
102 (30%) |
109 (23%) |
0.285 |
|
|
Comorbidities: 1 |
110 (30%) |
174 (32%) |
0.575 |
101 (30%) |
153 (32%) |
0.800 |
|
| Comorbidities: ≥2 | 142 (38%) | 242 (44%) | 0.088 | 131 (40%) | 220 (45%) | 0.390 | |
Data are presented as N, unless otherwise stated. Values are expressed as mean (SD).
BMI: Body Mass Index; VC: Vital Capacity; FEV1: Forced Expiratory Volume in 1 second; CAT: COPD Assessment Test.
°Y = includes currents smokers and ex-smokers.